Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
56,692,743
-
Shares change
-
+8,267,537
-
Total reported value, excl. options
-
$1,090,032,848
-
Value change
-
+$113,649,550
-
Put/Call ratio
-
36%
-
Number of buys
-
110
-
Number of sells
-
69
-
Price
-
$19.22
Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q3 2019
As of 30 Sep 2019 AERIE PHARMACEUTICALS INC - COM (AERI) had 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,692,743 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, BlackRock Inc., Foresite Capital Management III, LLC, WADDELL & REED FINANCIAL INC, Partner Fund Management, L.P., Foresite Capital Management II, LLC, Point72 Asset Management, L.P., and Foresite Capital Management IV, LLC.
This table shows 163 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.